Sign Up to like & get
recommendations!
0
Published in 2020 at "ESMO Open"
DOI: 10.1136/esmoopen-2020-000698
Abstract: Background In RECOURSE (, trifluridine/tipiracil significantly improved overall survival and progression-free survival (PFS) versus placebo in patients with pretreated metastatic colorectal cancer (mCRC). PRECONNECT was designed to further characterise safety and clinical use of trifluridine/tipiracil.…
read more here.
Keywords:
metastatic colorectal;
trifluridine tipiracil;
tipiracil;
safety ... See more keywords